Expression of adipokines in osteoarthritis osteophytes and their effect on osteoblasts

Matrix Biology

Volumn 62, Issue , 2017, Pages 75-91

  Junker, Susann ^a   Frommer, Klaus W ^a   Krumbholz, Grit ^a   Tsiklauri, Lali ^a   Gerstberger, Rüdiger ^a   Rehart, Stefan ^b   Steinmeyer, Jürgen ^c   Rickert, Markus ^c   Wenisch, Sabine ^a   Schett, Georg ^d   Müller Ladner, Ulf ^a   Neumann, Elena ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b AGAPLESION MARKUS KRANKENHAUS   (Germany)

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Adipokines; Osteoarthritis; Osteoblasts; Osteophytes

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADIPONECTIN RECEPTOR; AGGRECANASE 2; AXIN; BETA CATENIN; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGENASE 3; CYCLOPHILIN B; DICKKOPF 1 PROTEIN; GELATINASE B; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; RESISTIN; SCLEROSTIN; TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR SOX9; VASCULOTROPIN; WNT3A PROTEIN; ADIPOQ PROTEIN, HUMAN; CYTOKINE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN; RETN PROTEIN, HUMAN;

ARTICLE; CHONDROCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; OSTEOARTHRITIS; OSTEOBLAST; OSTEOCLAST; OSTEOPHYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WNT SIGNALING; AGED; CELL CULTURE; CELL DIFFERENTIATION; COMPLICATION; CYTOLOGY; GENE EXPRESSION REGULATION; MAPK SIGNALING; METABOLISM; VERY ELDERLY;

ADIPONECTIN; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OSTEOARTHRITIS; OSTEOBLASTS; OSTEOPHYTE; RESISTIN; WNT SIGNALING PATHWAY;

EID: 85007495444     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2016.11.005     Document Type: Article

References (81)

1. Goldring, M.B., Goldring, S.R., Osteoarthritis. J. Cell. Physiol. 213:3 (2007), 626–634.
2. Mahjoub, M., Berenbaum, F., Houard, X., Why subchondral bone in osteoarthritis? The importance of the cartilage bone interface in osteoarthritis. Osteoporos. Int. 23:Suppl. 8 (2012), S841–S846.
3. van der Kraan, P.M., van den Berg, W.B., Osteophytes: relevance and biology. Osteoarthr. Cartil. 15:3 (2007), 237–244.
4. Menkes, C.J., Lane, N.E., Are osteophytes good or bad. Osteoarthr. Cartil. 12:Suppl A (2004), S53–S54.
5. Felson, D.T., Gale, D.R., Elon Gale, M., Niu, J., Hunter, D.J., Goggins, J., Lavalley, M.P., Osteophytes and progression of knee osteoarthritis. Rheumatology (Oxford) 44:1 (2005), 100–104.
6. Kaneko, H., Ishijima, M., Futami, I., Tomikawa-Ichikawa, N., Kosaki, K., Sadatsuki, R., Yamada, Y., Kurosawa, H., Kaneko, K., Arikawa-Hirasawa, E., Synovial perlecan is required for osteophyte formation in knee osteoarthritis. Matrix Biol., 32(0), 2013, 10.1016/j.matbio.2013.01.004.
7. Hartmann, C., A Wnt canon orchestrating osteoblastogenesis. Trends Cell Biol. 16:3 (2006), 151–158.
8. Glass, D.A. 2nd, Bialek, P., Ahn, J.D., Starbuck, M., Patel, M.S., Clevers, H., Taketo, M.M., Long, F., McMahon, A.P., Lang, R.A., Karsenty, G., Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8:5 (2005), 751–764.
9. Richter, M., Trzeciak, T., Owecki, M., Pucher, A., Kaczmarczyk, J., The role of adipocytokines in the pathogenesis of knee joint osteoarthritis. Int. Orthop. 39:6 (2015), 1211–1217.
10. Thijssen, E., van Caam, A., van der Kraan, P.M., Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis. Rheumatology (Oxford) 54:4 (2015), 588–600.
11. Frommer, K.W., Schäffler, A., Buchler, C., Steinmeyer, J., Rickert, M., Rehart, S., Brentano, F., Gay, S., Müller-Ladner, U., Neumann, E., Adiponectin isoforms: a potential therapeutic target in rheumatoid arthritis?. Ann. Rheum. Dis. 71:10 (2012), 1724–1732.
12. Neumann, E., Frommer, K.W., Vasile, M., Müller-Ladner, U., Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases?. Arthritis Rheum. 63:5 (2011), 1159–1169.
13. Yokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., Kihara, S., Funahashi, T., Tenner, A.J., Tomiyama, Y., Matsuzawa, Y., Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96:5 (2000), 1723–1732.
14. Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., Yamashita, S., Funahashi, T., Matsuzawa, Y., Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100:25 (1999), 2473–2476.
15. Schäffler, A., Ehling, A., Neumann, E., Herfarth, H., Tarner, I., Scholmerich, J., Müller-Ladner, U., Gay, S., Adipocytokines in synovial fluid. JAMA 290:13 (2003), 1709–1710.
16. Ehling, A., Schäffler, A., Herfarth, H., Tarner, I.H., Anders, S., Distler, O., Paul, G., Distler, J., Gay, S., Scholmerich, J., Neumann, E., Müller-Ladner, U., The potential of adiponectin in driving arthritis. J. Immunol. 176:7 (2006), 4468–4478.
17. Patel, S.D., Rajala, M.W., Rossetti, L., Scherer, P.E., Shapiro, L., Disulfide-dependent multimeric assembly of resistin family hormones. Science 304:5674 (2004), 1154–1158.
18. Senolt, L., Housa, D., Vernerova, Z., Jirasek, T., Svobodova, R., Veigl, D., Anderlova, K., Muller-Ladner, U., Pavelka, K., Haluzik, M., Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann. Rheum. Dis. 66:4 (2007), 458–463.
19. Otero, M., Lago, R., Gomez, R., Lago, F., Dieguez, C., Gomez-Reino, J.J., Gualillo, O., Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann. Rheum. Dis. 65:9 (2006), 1198–1201.
20. Nowell, M.A., Richards, P.J., Fielding, C.A., Ognjanovic, S., Topley, N., Williams, A.S., Bryant-Greenwood, G., Jones, S.A., Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 54:7 (2006), 2084–2095.
21. Jia, S.H., Li, Y., Parodo, J., Kapus, A., Fan, L., Rotstein, O.D., Marshall, J.C., Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J. Clin. Invest. 113:9 (2004), 1318–1327.
22. Brentano, F., Schorr, O., Ospelt, C., Stanczyk, J., Gay, R.E., Gay, S., Kyburz, D., Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum. 56:9 (2007), 2829–2839.
23. Gosset, M., Berenbaum, F., Salvat, C., Sautet, A., Pigenet, A., Tahiri, K., Jacques, C., Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. Arthritis Rheum. 58:5 (2008), 1399–1409.
24. Stofkova, A., Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr. Regul. 44:1 (2010), 25–36.
25. Walsh, N.C., Reinwald, S., Manning, C.A., Condon, K.W., Iwata, K., Burr, D.B., Gravallese, E.M., Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J. Bone Miner. Res. 24:9 (2009), 1572–1585.
26. Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M.S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., van der Heide, D., Landewe, R., Lacey, D., Richards, W.G., Schett, G., Dickkopf-1 is a master regulator of joint remodeling. Nat. Med. 13:2 (2007), 156–163.
27. Heiland, G.R., Appel, H., Poddubnyy, D., Zwerina, J., Hueber, A., Haibel, H., Baraliakos, X., Listing, J., Rudwaleit, M., Schett, G., Sieper, J., High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann. Rheum. Dis. 71:4 (2012), 572–574.
28. Uderhardt, S., Diarra, D., Katzenbeisser, J., David, J.P., Zwerina, J., Richards, W., Kronke, G., Schett, G., Blockade of dickkopf (DKK)-1 induces fusion of sacroiliac joints. Ann. Rheum. Dis. 69:3 (2010), 592–597.
29. Rauner, M., Stein, N., Winzer, M., Goettsch, C., Zwerina, J., Schett, G., Distler, J.H.W., Albers, J., Schulze, J., Schinke, T., Bornhäuser, M., Platzbecker, U., Hofbauer, L.C., WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production. J. Bone Miner. Res. 27:3 (2012), 575–585.
30. Grünberg, J.R., Hammarstedt, A., Hedjazifar, S., Smith, U., The novel secreted adipokine WNT1-inducible signaling pathway protein 2 (WISP2) is a mesenchymal cell activator of canonical WNT. J. Biol. Chem. 289:10 (2014), 6899–6907.
31. Reinke, L., Lam, A.P., Flozak, A.S., Varga, J., Gottardi, C.J., Adiponectin inhibits Wnt co-receptor, Lrp6, phosphorylation and beta-catenin signaling. Biochem. Biophys. Res. Commun. 470:3 (2016), 606–612.
32. Ouchi, N., Higuchi, A., Ohashi, K., Oshima, Y., Gokce, N., Shibata, R., Akasaki, Y., Shimono, A., Walsh, K., Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329:5990 (2010), 454–457.
33. Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., Christy, W., Cooke, T.D., Greenwald, R., Hochberg, M., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 29:8 (1986), 1039–1049.
34. Gregory, C.A., Gunn, W.G., Peister, A., Prockop, D.J., An alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal. Biochem. 329:1 (2004), 77–84.
35. Junker, S., Krumbholz, G., Frommer, K.W., Rehart, S., Steinmeyer, J., Rickert, M., Schett, G., Muller-Ladner, U., Neumann, E., Differentiation of osteophyte types in osteoarthritis - proposal of a histological classification. Joint Bone Spine, 83(1), 2016, 63–67.
36. Gruber, H.E., Adaptations of Goldner's Masson trichrome stain for the study of undecalcified plastic embedded bone. Biotech. Histochem. 67:1 (1992), 30–34.
37. Meier, F.M.P., Frommer, K.W., Peters, M.A., Brentano, F., Lefévre, S., Schröder, D., Kyburz, D., Steinmeyer, J., Rehart, S., Gay, S., Müller-Ladner, U., Neumann, E., Visfatin/pre-B-cell colony-enhancing factor (PBEF), a proinflammatory and cell motility-changing factor in rheumatoid arthritis. J. Biol. Chem. 287:34 (2012), 28378–28385.
38. Frommer, K.W., Zimmermann, B., Meier, F.M., Schröder, D., Heil, M., Schäffler, A., Büchler, C., Steinmeyer, J., Brentano, F., Gay, S., Müller-Ladner, U., Neumann, E., Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis. Arthritis Rheum. 62:10 (2010), 2886–2899.
39. Ehling, A., Schaffler, A., Herfarth, H., Tarner, I.H., Anders, S., Distler, O., Paul, G., Distler, J., Gay, S., Scholmerich, J., Neumann, E., Muller-Ladner, U., The potential of adiponectin in driving arthritis. J. Immunol. 176:7 (2006), 4468–4478.
40. Conde, J., Scotece, M., Lopez, V., Abella, V., Hermida, M., Pino, J., Lago, F., Gomez-Reino, J.J., Gualillo, O., Differential expression of adipokines in infrapatellar fat pad (IPFP) and synovium of osteoarthritis patients and healthy individuals. Ann. Rheum. Dis. 73:3 (2014), 631–633.
41. Distel, E., Cadoudal, T., Durant, S., Poignard, A., Chevalier, X., Benelli, C., The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor. Arthritis Rheum. 60:11 (2009), 3374–3377.
42. Klein-Wieringa, I.R., Kloppenburg, M., Bastiaansen-Jenniskens, Y.M., Yusuf, E., Kwekkeboom, J.C., El-Bannoudi, H., Nelissen, R.G., Zuurmond, A., Stojanovic-Susulic, V., Van Osch, G.J., Toes, R.E., Ioan-Facsinay, A., The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Ann. Rheum. Dis. 70:5 (2011), 851–857.
43. van Tubergen, A., Ramiro, S., van der Heijde, D., Dougados, M., Mielants, H., Landewe, R., Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study. Ann. Rheum. Dis. 71:4 (2012), 518–523.
44. Goldring, S.R., Purdue, P.E., Crotti, T.N., Shen, Z., Flannery, M.R., Binder, N.B., Ross, F.P., McHugh, K.P., Bone remodelling in inflammatory arthritis. Ann. Rheum. Dis. 72:Suppl. 2 (2013), ii52–ii55.
45. Syrbe, U., Callhoff, J., Conrad, K., Poddubnyy, D., Haibel, H., Junker, S., Frommer, K.W., Müller-Ladner, U., Neumann, E., Sieper, J., Adipokine serum levels in patients with ankylosing spondylitis and their relation to clinical parameters and radiographic spinal progression. Arthritis Rheum., 2014 (n/a-n/a).
46. Conde, J., Scotece, M., Gomez, R., Lopez, V., Gomez-Reino, J.J., Gualillo, O., Adipokines and osteoarthritis: novel molecules involved in the pathogenesis and progression of disease. Arthritis, 2011, 2011, 203901.
47. Neumann, E., Knedla, A., Meier, F., Tarner, I.H., Büchler, C., Schäffler, A., Müller-Ladner, U., Adipozytokine als treibende Faktoren bei rheumatoider Arthritis. Z. Rheumatol. 66:2 (2007), 139–141.
48. Thommesen, L., Stunes, A.K., Monjo, M., Grosvik, K., Tamburstuen, M.V., Kjobli, E., Lyngstadaas, S.P., Reseland, J.E., Syversen, U., Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J. Cell. Biochem. 99:3 (2006), 824–834.
49. Kang, E.H., Lee, Y.J., Kim, T.K., Chang, C.B., Chung, J.H., Shin, K., Lee, E.Y., Lee, E.B., Song, Y.W., Adiponectin is a potential catabolic mediator in osteoarthritis cartilage. Arthritis Res Ther, 12(6), 2010, R231.
50. Koskinen, A., Juslin, S., Nieminen, R., Moilanen, T., Vuolteenaho, K., Moilanen, E., Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Res. Ther., 13(6), 2011, R184.
51. Conde, J., Scotece, M., Lopez, V., Gomez, R., Lago, F., Pino, J., Gomez-Reino, J.J., Gualillo, O., Adiponectin and leptin induce VCAM-1 expression in human and murine chondrocytes. PLoS One, 7(12), 2012, e52533.
52. Chen, T.H., Chen, L., Hsieh, M.S., Chang, C.P., Chou, D.T., Tsai, S.H., Evidence for a protective role for adiponectin in osteoarthritis. Biochim. Biophys. Acta 1762:8 (2006), 711–718.
53. Zhang, Z., Zhang, Z., Kang, Y., Hou, C., Duan, X., Sheng, P., Sandell, L.J., Liao, W., Resistin stimulates expression of chemokine genes in chondrocytes via combinatorial regulation of C/EBPbeta and NF-kappaB. Int. J. Mol. Sci. 15:10 (2014), 17242–17255.
54. Zhang, Z., Xing, X., Hensley, G., Chang, L.W., Liao, W., Abu-Amer, Y., Sandell, L.J., Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization. Arthritis Rheum. 62:7 (2010), 1993–2003.
55. Lee, J.H., Ort, T., Ma, K., Picha, K., Carton, J., Marsters, P.A., Lohmander, L.S., Baribaud, F., Song, X.Y., Blake, S., Resistin is elevated following traumatic joint injury and causes matrix degradation and release of inflammatory cytokines from articular cartilage in vitro. Osteoarthr. Cartil. 17:5 (2009), 613–620.
56. Laiguillon, M.C., Houard, X., Bougault, C., Gosset, M., Nourissat, G., Sautet, A., Jacques, C., Berenbaum, F., Sellam, J., Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis. Arthritis Res Ther, 16(1), 2014, R38.
57. Boström, E.A., Svensson, M., Andersson, S., Jonsson, I.M., Ekwall, A.K., Eisler, T., Dahlberg, L.E., Smith, U., Bokarewa, M.I., Resistin and insulin/insulin-like growth factor signaling in rheumatoid arthritis. Arthritis Rheum. 63:10 (2011), 2894–2904.
58. Moschen, A.R., Geiger, S., Gerner, R., Tilg, H., Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease. Mutat. Res. 690:1–2 (2010), 95–101.
59. Thommesen, L., Stunes, A.K., Monjo, M., Grosvik, K., Tamburstuen, M.V., Kjobli, E., Lyngstadaas, S.P., Reseland, J.E., Syversen, U., Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J. Cell. Biochem. 99:3 (2006), 824–834.
60. Oshima, K., Nampei, A., Matsuda, M., Iwaki, M., Fukuhara, A., Hashimoto, J., Yoshikawa, H., Shimomura, I., Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem. Biophys. Res. Commun. 331:2 (2005), 520–526.
61. Williams, G.A., Wang, Y., Callon, K.E., Watson, M., Lin, J.M., Lam, J.B., Costa, J.L., Orpe, A., Broom, N., Naot, D., Reid, I.R., Cornish, J., In vitro and in vivo effects of adiponectin on bone. Endocrinology 150:8 (2009), 3603–3610.
62. Yamaguchi, N., Kukita, T., Li, Y.J., Martinez Argueta, J.G., Saito, T., Hanazawa, S., Yamashita, Y., Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans. FEMS Immunol. Med. Microbiol. 49:1 (2007), 28–34.
63. Yamaguchi, N., Kukita, T., Li, Y.-J., Kamio, N., Fukumoto, S., Nonaka, K., Ninomiya, Y., Hanazawa, S., Yamashita, Y., Adiponectin inhibits induction of TNF-alpha/RANKL-stimulated NFATc1 via the AMPK signaling. FEBS Lett. 582:3 (2008), 451–456.
64. Luo, X.H., Guo, L.J., Xie, H., Yuan, L.Q., Wu, X.P., Zhou, H.D., Liao, E.Y., Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J. Bone Miner. Res. 21:10 (2006), 1648–1656.
65. Lee, Y.A., Ji, H.I., Lee, S.H., Hong, S.J., Yang, H.I., Chul Yoo, M., Kim, K.S., The role of adiponectin in the production of IL-6, IL-8, VEGF and MMPs in human endothelial cells and osteoblasts: implications for arthritic joints. Exp. Mol. Med., 46, 2013, e72.
66. Bokarewa, M., Nagaev, I., Dahlberg, L., Smith, U., Tarkowski, A., Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 174:9 (2005), 5789–5795.
67. Moschen, A.R., Kaser, A., Enrich, B., Mosheimer, B., Theurl, M., Niederegger, H., Tilg, H., Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J. Immunol. 178:3 (2007), 1748–1758.
68. Fadda, S.M., Gamal, S.M., Elsaid, N.Y., Mohy, A.M., Resistin in inflammatory and degenerative rheumatologic diseases. Relationship between resistin and rheumatoid arthritis disease progression. Z. Rheumatol. 72:6 (2013), 594–600.
69. Arboleya, L., Castaneda, S., Osteoimmunology: the study of the relationship between the immune system and bone tissue. Reumatol. Clin. 9:5 (2013), 303–315.
70. Caetano-Lopes, J., Canhao, H., Fonseca, J.E., Osteoimmunology - the hidden immune regulation of bone. Autoimmun. Rev. 8:3 (2009), 250–255.
71. Neumann, E., Müller-Ladner, U., Frommer, K.W., Entzündung und Knochenmetabolismus. Z. Rheumatol. 73:4 (2014), 342–348.
72. Yammani, R.R., Loeser, R.F., Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes. Arthritis Res Ther, 14(1), 2012, R23.
73. Mattu, H.S., Randeva, H.S., Role of adipokines in cardiovascular disease. J. Endocrinol. 216:1 (2013), T17–T36.
74. Romacho, T., Sanchez-Ferrer, C.F., Peiro, C., Visfatin/Nampt: an adipokine with cardiovascular impact. Mediat. Inflamm., 2013, 2013, 946427.
75. Evans, L., Williams, A.S., Hayes, A.J., Jones, S.A., Nowell, M., Suppression of leukocyte infiltration and cartilage degradation by selective inhibition of pre-B cell colony-enhancing factor/visfatin/nicotinamide phosphoribosyltransferase: Apo866-mediated therapy in human fibroblasts and murine collagen-induced arthritis. Arthritis Rheum. 63:7 (2011), 1866–1877.
76. Verma, S., Li, S.H., Wang, C.H., Fedak, P.W., Li, R.K., Weisel, R.D., Mickle, D.A., Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108:6 (2003), 736–740.
77. Blumenthal, A., Ehlers, S., Lauber, J.r., Buer, J., Lange, C., Goldmann, T., Heine, H., Brandt, E., Reiling, N., The Wingless Homolog WNT5A and its recepTor Frizzled-5 Regulate Inflammatory Responses of Human Mononuclear Cells Induced by Microbial Stimulation. 2006.
78. Gustafson, B., Smith, U., Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J. Biol. Chem. 281:14 (2006), 9507–9516.
79. Chen, X., Lu, J., Bao, J., Guo, J., Shi, J., Wang, Y., Adiponectin: a biomarker for rheumatoid arthritis?. Cytokine Growth Factor Rev. 24:1 (2013), 83–89.
80. Gkretsi, V., Simopoulou, T., Tsezou, A., Lipid metabolism and osteoarthritis: lessons from atherosclerosis. Prog. Lipid Res. 50:2 (2011), 133–140.
81. Frommer, K.W., Schaffler, A., Rehart, S., Lehr, A., Muller-Ladner, U., Neumann, E., Free fatty acids: potential proinflammatory mediators in rheumatic diseases. Ann. Rheum. Dis. 74:1 (2015), 303–310.